Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Operating Income Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-8.23%
↓ 131% below average
Average (9y)
26.83%
Historical baseline
Range
High:150.15%
Low:-39.80%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -8.23% |
| 2023 | -19.26% |
| 2022 | -39.80% |
| 2021 | 150.15% |
| 2020 | 61.85% |
| 2019 | -12.81% |
| 2018 | 21.87% |
| 2017 | 56.27% |
| 2016 | 6.30% |
| 2015 | 51.95% |